ASF1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.761600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.324300E-02
Normal-vs-Stage2
1.744920E-03
Normal-vs-Stage3
1.021750E-02
Normal-vs-Stage4
8.392100E-02
Stage1-vs-Stage2
7.552800E-01
Stage1-vs-Stage3
5.147800E-01
Stage1-vs-Stage4
9.504000E-01
Stage2-vs-Stage3
6.297000E-01
Stage2-vs-Stage4
8.669400E-01
Stage3-vs-Stage4
6.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.316100E-03
Normal-vs-AfricanAmerican
4.531800E-02
Normal-vs-Asian
4.429800E-02
Caucasian-vs-AfricanAmerican
4.139600E-01
Caucasian-vs-Asian
7.922800E-01
AfricanAmerican-vs-Asian
4.897600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.316140E-03
Normal-vs-Female
1.369670E-02
Male-vs-Female
1.295430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.347800E-02
Normal-vs-Age(41-60Yrs)
7.521500E-03
Normal-vs-Age(61-80Yrs)
4.737700E-03
Normal-vs-Age(81-100Yrs)
2.575800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.420600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.515200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.148600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.742000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.970400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.353000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.522920E-03
Normal-vs-Daily Drinker
2.45649999999209E-05
Normal-vs-Weekly Drinker
2.016700E-03
Normal-vs-Occasional Drinker
1.106780E-01
Normal-vs-Social Drinker
9.420200E-03
Non Drinker-vs-Daily Drinker
1.203170E-01
Non Drinker-vs-Weekly Drinker
5.816800E-01
Non Drinker-vs-Occasional Drinker
2.540000E-01
Non Drinker-vs-Social Drinker
5.572800E-01
Daily Drinker-vs-Weekly Drinker
4.421800E-01
Daily Drinker-vs-Occasional Drinker
3.971700E-02
Daily Drinker-vs-Social Drinker
5.321900E-02
Weekly Drinker-vs-Occasional Drinker
1.783630E-01
Weekly Drinker-vs-Social Drinker
3.329800E-01
Occasional Drinker-vs-Social Drinker
5.377600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.101200E-01
Normal-vs-Grade 2
6.825600E-01
Normal-vs-Grade 3
2.891000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.851600E-01
Grade 1-vs-Grade 3
4.220000E-01
Grade 1-vs-Grade 4
3.101200E-01
Grade 2-vs-Grade 3
8.370200E-01
Grade 2-vs-Grade 4
6.825600E-01
Grade 3-vs-Grade 4
2.891000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.300030E-03
Normal-vs-NonDiabetic
1.923850E-03
Diabetic-vs-NonDiabetic
5.120000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.5363000000066E-05
Normal-vs-NoPancreatitis
2.978500E-03
Pancreatitis-vs-NoPancreatitis
4.416000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.466100E-02
Normal-vs-N1
1.283010E-03
N0-vs-N1
3.642200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.581760E-02
Normal-vs-TP53-NonMutant
7.216000E-02
TP53-Mutant-vs-TP53-NonMutant
1.520160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
